Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

China · Delayed Price · Currency is CNY

18.77

+0.19 (1.02%)

Jul 31, 2026, 3:00 PM CST

SHA:600645 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,421	1,455	1,585	1,590	1,555	1,535
Revenue Growth	-7.59%	-8.23%	-0.27%	2.24%	1.27%	16.41%
Gross Profit	977.34	996.22	1,088	1,085	1,045	1,061
Operating Income	150.82	153.18	163.2	138.14	142.93	124.44
Net Income	110.05	113.83	100.35	106.45	112.99	155.32
Earnings Per Share	0.24	0.25	0.22	0.23	0.24	0.33
EPS Growth	25.17%	13.64%	-4.35%	-4.17%	-27.27%	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Service Industry	419.31
Manufacturing Industry	1,036
Total	1,455

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,735	1,722	1,528	1,581	1,393	1,196
Total Debt	85.92	80.27	123.75	127.48	141.18	82.2
Net Cash (Debt)	1,649	1,642	1,404	1,454	1,252	1,113
Net Cash Growth	15.16%	16.94%	-3.42%	16.09%	12.46%	11.14%
Net Cash Per Share	3.59	3.61	3.08	3.14	2.66	2.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	295.38	313.63	285.19	299.02	261.89	320.96
Capital Expenditures	-46.84	-49.56	-67.32	-88.61	-99.19	-127.74
Free Cash Flow	248.55	264.07	217.87	210.4	162.7	193.22
Free Cash Flow Growth	-1.54%	21.21%	3.55%	29.32%	-15.79%	26.59%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.75%	68.47%	68.61%	68.23%	67.18%	69.14%
Operating Margin	10.61%	10.53%	10.29%	8.69%	9.19%	8.11%
Pretax Margin	12.34%	11.99%	8.57%	8.34%	9.98%	14.52%
Profit Margin	7.74%	7.82%	6.33%	6.70%	7.27%	10.12%
FCF Margin	17.48%	18.15%	13.74%	13.23%	10.46%	12.58%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	78.42	100.93	87.68	89.10	70.45	76.04
Forward PE	-	72.92	56.77	48.99	48.99	48.99
P/FCF Ratio	34.43	43.51	40.39	45.08	48.92	61.13
PS Ratio	6.02	7.90	5.55	5.97	5.12	7.69